Prot. 7163-CL-3201: A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de novo Kidney Transplant Recipients

  • Gallon, Lorenzo (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/13/1710/13/20

Funding

  • Astellas Pharma Global Development, Inc. (Prot. 7163-CL-3201)